JP Morgan Maintains Neutral on Bilibili, Raises Price Target to $25

JP Morgan analyst Alex Yao maintains Bilibili (NASDAQ:BILI) with a Neutral and raises the price target from $19 to $25.

byBenzinga Newsdesk

June 13, 2022

1 minute read

JP Morgan analyst Alex Yao maintains Bilibili (NASDAQ:BILI) with a Neutral and raises the price target from $19 to $25.

L.B. Foster And FUCHS Announce Strategic Partnership To Develop Industry-Leading Friction Management Products For The Global Rail Markets

By Benzinga Newsdesk

December 14, 3:08 PM

L.B. Foster Company (NASDAQ:FSTR), a global solutions provider of products and services for the rail and infrastructure markets ("L.B. Foster" or the "Company"), is pleased to announce a strategic

FSTR

FDA
News

Biofrontera Inc. Announces FDA Orange Book Listing Of US Patent For BF-RhodoLED XL Extending Protection Of Ameluz-PDT Through October 2040

By Bill Haddad

March 14, 9:26 AM

Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the previously granted U.S. patent No. 11,235,169 (the

BFRI